Digital Health Startups

Aranda is a pharmaceutical company focused on developing and commercializing prescription and OTC products. The company leverages leadership experience in international pharmaceutical business development and product registration across European markets.

1 investor

ARANZ Medical develops Silhouette, a wound care workflow platform for clinicians that tracks, charts, and reports on wound healing while connecting to clinical, billing, and supply management systems. It is used in pre-clinical to phase 4 clinical trials and offers telehealth capabilities for remote information sharing between clinicians and patients.

1 investor

Arbizal builds custom AI agents on its platform and migrates healthcare organizations' operations onto them one workflow at a time, covering tasks like prior authorization, intake, chart abstraction, and reporting. It serves health systems, clinical research organizations, community and rural health providers, and healthcare services companies, with encryption, role-based access, and audit trails built in.

1 investor

Arborsense develops transdermal wearable sensors that monitor biomarkers in sweat, including the SCANar wrist-worn sweat collection device, providing non-invasive alcohol and substance monitoring. Its products target compliance use cases in law enforcement, workplace safety, rehabilitation, and healthcare, as well as research into substance use, metabolic health, and disease.

1 investor

Arboretum provides genetic testing programs and patient registry infrastructure for healthcare systems to implement precision medicine for cardiovascular disease, cancer, and metabolic conditions. The company enables clinical integration and translational research to accelerate precision medicine trials.

1 investor

AFX Medical develops artificial intelligence software for cancer treatment management and clinical decision support integrated into medical devices for healthcare providers. The company serves oncology clinics and hospitals seeking to improve patient outcomes through AI-augmented diagnostic and treatment tools.

1 investor

Arcturis curates precision, regulatory-grade real-world health data from secondary-care patient records enriched with unstructured, molecular and genetic data. It serves life science and pharmaceutical clients to support drug discovery, development and launch, with coverage across the UK population and therapeutic areas including oncology, respiratory, cardiovascular, metabolic and rare diseases.

1 investor

Arda Therapeutics is a drug development company that uses single-cell computational biology to identify and eliminate pathogenic cells as a way to treat chronic diseases. It operates in the biotechnology and therapeutics sector.

1 investor

Ardigen is an AI-powered contract research organization (CRO) that applies artificial intelligence, bioinformatics, and machine learning to drug discovery and development, turning biomedical data into predictions for its clients' pipelines. It serves biotech and pharmaceutical companies with services spanning discovery, development, data management, and infrastructure.

1 investor

Argonaute RNA develops siRNA-based (RNA interference) therapeutics, with a pipeline focused on cardiovascular disease, combining oligonucleotide chemistry and drug development expertise. The UK biotech takes early-stage academic ideas through preclinical and clinical development.

1 investor

Aridhia provides the DRE, a certified cloud-based Trusted Research Environment for securely storing, governing, sharing, and analysing sensitive health data. It serves research hospitals, global consortia, and life sciences organisations, supporting tools like Python and R, federated analytics, and air-gapped LLM deployment while maintaining compliance and audit trails.

1 investor

Ariel Precision Medicine offers an AI-driven platform that integrates genomic and clinical data (including EHR/EMR records, lab results, and scientific literature) to produce peer-reviewed, evidence-based reports. It serves clinicians diagnosing complex diseases and therapeutics developers seeking target discovery and patient stratification.

1 investor

Arion Care (美中爱瑞) is an oncology-focused hospital in China providing cancer diagnosis and treatment through multidisciplinary team (MDT) consultations and specialized centers for lung, breast, gastrointestinal, gynecologic, urologic, hepatobiliary, lymphoma, neurologic, and other cancers. It offers services such as case managers, radiotherapy, precision health medicine, cancer rehabilitation, and commercial insurance direct billing for patients.

1 investor

Arkstone offers an "expert-in-the-loop" AI platform for clinical decision support focused on infectious disease diagnosis and antimicrobial stewardship, providing evidence-based treatment guidance via its OneChoice report. It serves laboratories, hospitals, telemedicine providers, and skilled nursing facilities, helping clinicians make treatment decisions aligned with CDC, IDSA, WHO, and EUCAST guidelines.

1 investor

AROMICS is a biotech company that discovers and develops new drugs and diagnostic methods using OMIC technologies to target human diseases. It works on understanding drug mechanisms and identifying molecular endpoints to help physicians manage diseases and monitor drug response.

1 investor

Arosa provides home care and home health care services, including help with daily tasks, for families and their loved ones. The company serves the Shelbyville area.

1 investor

Arpi develops AI-based ECG analysis software for clinical use, providing arrhythmia classification and cardiovascular biomarker risk scores from a single electrocardiogram. Its tools are aimed at clinicians in emergency, clinic, and outpatient settings to detect cardiac risks such as STEMI, hyperkalemia, and left ventricular dysfunction.

1 investor

Advanced Reconstructive Surgery Alliance (ARSA) is a physician practice management organization (MSO) that provides business support—including compliance, credentialing, finance, HR, IT, marketing, M&A, revenue cycle management, and research—to reconstructive and cosmetic surgery practices. It operates a national network of more than 80 physicians across multiple U.S. states under a "PrivAdemic" model combining private practice with academic collaboration.

1 investor

Arsipa is a group of occupational medicine and workplace safety providers offering companies preventive health services and safety management (Grundbetreuung and betriebsspezifische Betreuung per DGUV V2). It serves employers across Germany and Austria with on-site care through a network of local specialists.

1 investor

Japanese company providing personal health record (PHR) services that use individual health data to deliver personalized health advice, including apps such as "パシャっとカルテ" and dietary support tools. It works on health-related pilot projects, including initiatives backed by Japan's Ministry of Economy, Trade and Industry.

1 investor

ArtesRx acquires and operates a network of regional specialty and community pharmacies ("Regional Care Hubs") that provide high-touch medication services for patients with complex medication needs. It serves patients across multiple U.S. states with a focus on medication access, adherence, and clinical care.

1 investor

Arthrosi Therapeutics is a clinical-stage biotech company developing AR882 (pozdeutinurad), a urate-lowering drug candidate for gout, tophaceous gout, and chronic kidney disease. The company is running Phase 3 trials for its treatment aimed at patients with gout, including those with tophi and chronic refractory gout.

1 investor

Arul Health is building a patient navigation service that bridges healthcare and social care, helping people with serious diagnoses coordinate care, advocate on their behalf, and contest costs. It supports patients and their families through the practical and emotional challenges of illness.

1 investor

Asato offers software that analyzes healthcare clinic operations to surface inefficiencies, compliance risks, and cost-saving opportunities across both physical and online clinics. It aims to give clinic operators clearer, synthesized data on software, medical devices, and staffing.

1 investor